Viking Therapeutics says its experimental tablet reduced weight in early-stage study-March 2024-www.financetom.com

Viking Therapeutics says its experimental tablet reduced weight in early-stage study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Viking Therapeutics says its experimental tablet reduced weight in early-stage study

Mar 26, 2024 4:20 AM

March 26 (Reuters) - Viking Therapeutics ( VKTX ) said

on Tuesday its experimental tablet helped reduce weight in

patients in an early-stage trial and was shown to be safe and

effective in the study.

The company said it plans to initiate a phase 2 trial later

this year, based on the early-stage data.

Previous page： Sterling Check Insider Sold Shares Worth $377,813, According to a Recent SEC Filing Next page： Cytokinetics Insider Sold Shares Worth $278,050, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sterling Check Insider Sold Shares Worth $377,813, According to a Recent SEC Filing

Oct 10, 2024

04:13 PM EDT, 10/10/2024 (MT Newswires) -- Melanie Laird, 10% Owner, on September 20, 2024, sold 22,278 shares in Sterling Check ( STER ) for $377,813. Following the Form 4 filing with the SEC, Laird has control over a total of 11,049,576 shares of the company, with 11,049,576 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1645070/000114036124043276/xslF345X05/form4.xml ...

Cytokinetics Insider Sold Shares Worth $278,050, According to a Recent SEC Filing

Oct 10, 2024

04:07 PM EDT, 10/10/2024 (MT Newswires) -- Robert I Blum, Director, President & CEO, on October 09, 2024, sold 5,000 shares in Cytokinetics ( CYTK ) for $278,050. Following the Form 4 filing with the SEC, Blum has control over a total of 401,622 shares of the company, with 397,456 shares held directly and 4,166 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1061983/000112760224025384/xslF345X05/form4.xml...

Intapp Insider Sold Shares Worth $901,718, According to a Recent SEC Filing

Oct 10, 2024

04:11 PM EDT, 10/10/2024 (MT Newswires) -- Thad Jampol, Chief Product Officer, on October 08, 2024, sold 20,000 shares in Intapp ( INTA ) for $901,718. Following the Form 4 filing with the SEC, Jampol has control over a total of 837,440 shares of the company, with 772,412 shares held directly and 65,028 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1565687/000112760224025388/xslF345X05/form4.xml ...

BRIEF-Synergy Chc Corp Now Sees IPO Of 1 Million Shares Of Common Stock- SEC Filing

Oct 10, 2024

* SYNERGY CHC CORP NOW SEES IPO OF 1 MILLION SHARES OF COMMON STOCK- SEC FILING Source text for Eikon: Further company coverage: [ ] ...